GLP & Metabolic

Incretin and energy-balance research compounds

Incretin receptor agonists and adjacent metabolic compounds — the most heavily published peptide class of the last decade. Every lot in this category ships with dual-orthogonal identity confirmation, because sequence-adjacent analogues are the easiest place for a supply chain to go wrong.

7 compounds in this class